Family perspectives on end-of-life care at the last place of care

…, BR Clarridge, V Casey, LC Welch, T Wetle, R Shield… - Jama, 2004 - jamanetwork.com
ContextOver the past century, nursing homes and hospitals increasingly have become the
site of death, yet no national studies have examined the adequacy or quality of end-of-life …

Data withholding in academic genetics: evidence from a national survey

EG Campbell, BR Clarridge, M Gokhale, L Birenbaum… - jama, 2002 - jamanetwork.com
ContextThe free and open sharing of information, data, and materials regarding published
research is vital to the replication of published results, the efficient advancement of science, …

Linguistic and cultural barriers to care: perspectives of Chinese and Vietnamese immigrants

Q Ngo-Metzger, MP Massagli, BR Clarridge… - Journal of general …, 2003 - Springer
CONTEXT: Primarily because of immigration, Asian Americans are one of the fastest growing
and most ethnically diverse minority groups in the United States. However, little is known …

Euthanasia and physician-assisted suicide: attitudes and experiences of oncology patients, oncologists, and the public

EJ Emanuel, ER Daniels, DL Fairclough, BR Clarridge - The Lancet, 1996 - Elsevier
Background Euthanasia and physician-assisted suicide are pressing public issues. We aimed
to collect empirical data on these controversial interventions, particularly on the attitudes …

The practice of euthanasia and physician-assisted suicide in the United States: adherence to proposed safeguards and effects on physicians

EJ Emanuel, ER Daniels, DL Fairclough, BR Clarridge - Jama, 1998 - jamanetwork.com
Context.—Despite intense debates about legalization, there are few data examining the
details of actual euthanasia and physician-assisted suicide (PAS) cases in the United States.…

Patients' views on identifiability of samples and informed consent for genetic research

…, D Bolcic-Jankovic, BR Clarridge… - The American Journal …, 2008 - Taylor & Francis
It is unclear whether the regulatory distinction between non-identifiable and identifiable
information—information used to determine informed consent practices for the use of clinically …

[HTML][HTML] Academic medical centers' standards for clinical-trial agreements with industry

MM Mello, BR Clarridge… - New England Journal of …, 2005 - Mass Medical Soc
Background Although industry sponsors provide approximately 70 percent of the funding for
clinical drug trials in the United States, little is known about the legal agreements that exist …

Reconciling medications at admission: safe practice recommendations and implementation strategies

…, LL Leape, L Kirle, N Ridley, BR Clarridge… - The Joint Commission …, 2006 - Elsevier
Article-at-a-Glance Background Fifty hospitals collaborated in a patient safety initiative
developed and implemented by the Massachusetts Coalition for the Prevention of Medical Errors …

Complementary and alternative medical therapy use among Chinese and Vietnamese Americans: prevalence, associated factors, and effects of patient–clinician …

…, MP Massagli, BR Clarridge… - … Journal of Public …, 2006 - ajph.aphapublications.org
Objective. We examined the use of complementary and alternative medical (CAM) therapies
among Chinese and Vietnamese Americans who had limited proficiency with the English …

[HTML][HTML] Financial relationships between institutional review board members and industry

…, JS Weissman, C Vogeli, BR Clarridge… - … England Journal of …, 2006 - Mass Medical Soc
Background Little is known about the nature, extent, and consequences of financial relationships
between industry and institutional review board (IRB) members in academic institutions…